INTERVIEW: One year on - how has CardioMEMS worked out for St Jude?
This article was originally published in Clinica
Executive Summary
A few weeks ago, St. Jude Medical marked the one-year anniversary of its acquisition of CardioMEMS, developer of the CardioMEMS HF System, which became the first US FDA-approved heart failure monitor proven to significantly reduce HF hospital admissions and improve quality of life in New York Heart Association (NYHA) class III patients.